LifeStance Health Group (NASDAQ:LFST) Earns Buy Rating from Analysts at Canaccord Genuity Group

Canaccord Genuity Group began coverage on shares of LifeStance Health Group (NASDAQ:LFST) in a research note issued to investors on Thursday, Marketbeat reports. The firm issued a buy rating and a $8.00 target price on the stock.

Other equities analysts have also recently issued research reports about the company. William Blair restated an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. The Goldman Sachs Group raised shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $8.50.

LifeStance Health Group Stock Performance

Shares of LFST stock opened at $6.64 on Thursday. The company’s fifty day simple moving average is $7.47 and its 200-day simple moving average is $7.34. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group has a 52 week low of $4.64 and a 52 week high of $8.61. The company has a market cap of $2.55 billion, a PE ratio of -25.54 and a beta of 1.30.

Insider Activity

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the transaction, the insider now directly owns 339,810 shares in the company, valued at $2,344,689. This trade represents a 5.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 6.60% of the company’s stock.

Hedge Funds Weigh In On LifeStance Health Group

A number of large investors have recently made changes to their positions in the business. Blue Trust Inc. boosted its position in LifeStance Health Group by 124.4% during the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock valued at $27,000 after purchasing an additional 2,122 shares during the last quarter. Townsquare Capital LLC acquired a new stake in shares of LifeStance Health Group during the 3rd quarter valued at about $73,000. R Squared Ltd bought a new stake in shares of LifeStance Health Group in the 4th quarter valued at approximately $80,000. Ameriprise Financial Inc. acquired a new position in LifeStance Health Group in the fourth quarter worth approximately $87,000. Finally, Cibc World Markets Corp bought a new position in LifeStance Health Group during the fourth quarter valued at approximately $96,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.